In diffuse large B-cell lymphoma, silencing GPNMB can inhibit the nuclear translocation of β-catenin protein and weaken the malignant phenotype of tumor cells, which promotes tumor progression through the Wnt pathway (Wang et al., 2021b). This evidence concerns the gene GPNMB and neoplasm.